InSingulo AB logo

InSingulo AB

The right environment for drug discovery

11 employees · est. 2017 · Sweden

VS
KSQ Therapeutics, Inc. logo

KSQ Therapeutics, Inc.

The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates

60 employees · est. 2015 · Lexington, United States

KSQ Therapeutics, Inc. is the older company (2017 vs 2015); KSQ Therapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

InSingulo AB KSQ Therapeutics, Inc.
Founded
2017 2015 older
Headquarters
Sweden Lexington, United States
Employees
11 60 larger
Industry
Biotechnology, Health Care, Life Sciences Biopharma, Biotechnology, Health and Wellness
Funding Stage
Seed Series C
Total Funding
Not tracked yet $166.00M
Funding Rounds
Not tracked yet 4
Services
Not tracked yet CRISPRomics Platform, Cancer Drug Development, Pipeline Advancements, Partnerships for Drug Development
Target Customers
Not tracked yet Healthcare Providers, Cancer Patients, Research Institutions, Pharmaceutical Companies
Taxonomy
Drug Discovery, Biosensing Technology, Characterization Of Drug Interactions, Membrane Proteins, Drug Screening, Therapeutic Targets, Single Molecule Level, Native Environment, Complex Targets, Pharmaceutical Research CRISPRomics, Drug Development, Functional Genomics, Tumor-focused Therapies, Immune-focused Therapies, Genome-scale Precision, Therapeutic Nodes, Genomic Function, High-Confidence Drug Development, Preclinical Discovery Programs, CRISPR Screening Technologies, Disease Biology, Patient-tailored Drug Targets, Innovative R&D Approach, Novel Drug Targets
Website
insingulo.com ksqtx.com
InSingulo AB logo

About InSingulo AB

InSingulo AB is a biotechnology startup based in Sweden, founded in 2017. The company's slogan "The right environment for drug discovery" underscores their focus on providing an optimal setting for drug development. InSingulo specializes in the characterization of drug interactions with complex targ...

KSQ Therapeutics, Inc. logo

About KSQ Therapeutics, Inc.

KSQ Therapeutics, Inc. stands as a pioneering entity in the biopharmaceutical industry, leveraging its industry-leading CRISPRomics platform to revolutionize drug development. Based in Cambridge, Massachusetts, the company focuses on pinpointing therapeutic nodes that directly correlate genomic func...

We will tell you when either one moves

BounceWatch watches InSingulo AB and KSQ Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at InSingulo AB and KSQ Therapeutics, Inc. — by email.

Frequently Asked Questions

InSingulo AB — The right environment for drug discovery. KSQ Therapeutics, Inc. — The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
InSingulo AB has raised undisclosed funding while KSQ Therapeutics, Inc. has raised $166.00M.
InSingulo AB and KSQ Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare InSingulo AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at InSingulo AB on 12 Sep 2024, and KSQ Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes